[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"developmental-coordination-disorder-dcd\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:developmental-coordination-disorder-dcd":27},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,4,0,[8,43,73,103],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":28,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":31,"lastUpdatePostDateStruct":32,"startDateStruct":35,"completionDateStruct":37,"leadSponsor":39,"locationsCount":42},"100642348","obstacle-course-versus-neuromotor-task-training-in-children-with-dcd-100642348",false,"NCT07575178","Obstacle Course Versus Neuromotor Task Training in Children With DCD","Comparison of Obstacle Course Training and Neuromotor Task Training on Motor Planning and Functional Mobility in Children With Developmental Coordination Disorder","Inclusion Criteria:\n\n* • Diagnosis of DCD based on DSM4\u002F5 criteria.\n\n  * Children aged 7-10.\n  * Gender male and female.\n  * Mini-Mental State Examination (MMSE) score \\>24 .\n  * Cognitive development appropriate for chronological age.\n  * Raven Intelligence Test Scale (IQ \\> 75) .\n  * Developmental Coordination Questionnaire ≤48 points: likely DCD (≤ 10th percentile).\n  * BOT-2 score ≤ 40.\n\nExclusion Criteria:\n\n* History of surgery and lower limb injuries over the past 12 months.\n* Use of assistive devices to balance and walk.\n* Severe ADHD, Autism Spectrum Disorder (if it significantly interferes with participation), or major psychiatric disorders.\n* Taking neuroleptics or any other medications that significantly alter muscle tone, coordination, or attention.","ALL","7 Years","10 Years",{"count":20,"type":21},28,"ESTIMATED","INTERVENTIONAL",[24],"NA","Developmental Coordination Disorder (DCD) affects motor planning and functional mobility in children, leading to long-term functional and psychosocial difficulties. This randomized clinical trial will compare the effectiveness of Obstacle Course Training (OCT) and Neuromotor Task Training (NTT) in improving motor planning and functional mobility in children aged 7-10 years diagnosed with DCD. Participants will be randomly allocated to either OCT or NTT for 9 weeks (two sessions per week). Outcomes will be assessed using standardized motor performance measures to determine the more effective intervention.",[27],"Developmental Coordination Disorder (DCD)",[29],"DCD, Motor coordination, Neuromotor training,","NOT_YET_RECRUITING","2026-06-08",{"date":33,"type":34},"2026-06-10","ACTUAL",{"date":36,"type":21},"2026-06",{"date":38,"type":21},"2026-08-01",{"name":40,"class":41},"Riphah International University","OTHER",1,{"id":44,"slug":45,"hasResults":11,"nctId":46,"briefTitle":47,"officialTitle":48,"acronym":49,"eligibilityCriteria":50,"healthyVolunteers":11,"sex":16,"minAge":51,"maxAge":52,"enrollmentInfo":53,"targetDuration":4,"studyType":22,"phases":55,"briefSummary":56,"conditions":57,"keywords":58,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":64,"lastUpdatePostDateStruct":65,"startDateStruct":67,"completionDateStruct":69,"leadSponsor":71,"locationsCount":4},"100639570","therapeutic-climbing-for-children-with-dcd-100639570","NCT07609563","Therapeutic Climbing for Children With DCD","Therapeutic Group Climbing for Children With Developmental Coordination Disorder: Randomized Crossover Trial","Climbing TDC","Inclusion Criteria:\n\n* Diagnosis of DCD by a physician\\*.\n* Ability to follow instructions, communicate verbally, interact with adults and peers, and use cognitive strategies.\n* Ability to attend all assessment and intervention sessions in Sherbrooke.\n* Ability to understand and speak French.\n* Provision of child assent and parental consent. \\* If the target sample size (n = 16) is not reached, children with suspected DCD based on the Developmental Coordination Disorder Questionnaire (DCDQ) (25,26) will also be considered. Eligibility will then require: (1) a score below the 15th percentile on the total motor composite or below the 5th percentile in a domain of the Bruininks-Oseretsky Test of Motor Proficiency (BOT) (27,28), and (2) the identification of occupational challenges using the Canadian Occupational Performance Measure (COPM) (29,30) during the initial assessment.\n\nExclusion Criteria:\n\n* Diagnosis of severe behavioral disorders, autism spectrum disorder, intellectual disability, cerebral palsy, muscular dystrophy, and\u002For severe functional limitations.\n* Prior proficiency in climbing or absence of climbing-related goals.","8 Years","12 Years",{"count":54,"type":21},16,[24],"This study looks at whether therapeutic climbing - indoor climbing activities guided by therapists - can help children with Developmental Coordination Disorder (DCD).\n\nDCD is a condition where children have difficulty with motor skills and participation in everyday activities, and sometimes confidence in physical activities.\n\nThe climbing program is based on a problem-solving approach called CO-OP (Cognitive Orientation to daily Occupational Performance), in which children learn strategies to achieve goals.",[27],[59,60,61,62,63],"Therapeutic climbing","Neurodevelopmental condition","Group intervention","Participation-oriented approach","Occupational therapy","2026-05-27",{"date":66,"type":34},"2026-06-01",{"date":68,"type":21},"2026-05-15",{"date":70,"type":21},"2026-06-06",{"name":72,"class":41},"Université de Sherbrooke",{"id":74,"slug":75,"hasResults":11,"nctId":76,"briefTitle":77,"officialTitle":78,"acronym":79,"eligibilityCriteria":80,"healthyVolunteers":81,"sex":16,"minAge":82,"maxAge":83,"enrollmentInfo":84,"targetDuration":4,"studyType":86,"phases":4,"briefSummary":87,"conditions":88,"keywords":91,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":95,"lastUpdatePostDateStruct":96,"startDateStruct":98,"completionDateStruct":99,"leadSponsor":101,"locationsCount":42},"100636799","biomarkers-of-asdadhd-and-factors-affecting-anxiety-and-depression-in-children-and-young-adults-100636799","NCT07570381","Biomarkers of ASD\u002FADHD and Factors Affecting Anxiety and Depression in Children and Young Adults","Biomarker Discovery for Predicting Autism Spectrum Disorder and Attention\u002FHyperactivity Disorders, and Identification of Environmental Factors Influencing Anxiety and Depression in Children, Adolescents, and Young Adults","PUREMIND-OS","OS1 Inclusion Criteria:\n\n* Infants born very preterm (\\\u003C32 weeks) or extremely preterm (\\\u003C28 weeks); or\n* Term-born infants with documented perinatal asphyxia and hypoxic-ischaemic encephalopathy (HIE); or\n* Term-born infants with no risk factors (comparison group).\n* Must be ≤12 months corrected age at enrolment.\n\nOS1 Exclusion Criteria:\n\n* Syndromic, chromosomal, or known genetic conditions.\n* Motor impairments that would prevent participation in psychometric or neurophysiology assessments.\n\nOS2 Inclusion Criteria:\n\n* Individuals aged 5-25 years.\n* Clinical diagnosis of ASD, ADHD, or Developmental Coordination Disorder (DCD).\n* Able to participate in scheduled assessments.\n\nOS2 Exclusion Criteria:\n\n* Severe motor impairments that limit psychometric assessment.\n* Diagnosis of schizophrenia, due to confounding neurocognitive effects.",true,"6 Months","25 Years",{"count":85,"type":21},800,"OBSERVATIONAL","The PUREMIND OS1\u002FOS2 study is a multinational, prospective, longitudinal observational study designed to identify early neurophysiological, biological, environmental, and psychosocial markers associated with neurodevelopmental and mental health conditions from infancy through young adulthood.\n\nObservational Study 1 (OS1) follows infants and toddlers at high risk for Autism Spectrum Disorder (ASD) and Attention-Deficit\u002FHyperactivity Disorder (ADHD) to discover biomarkers predictive of later clinical diagnosis, using EEG, fNIRS, psychometric assessments, and biological samples.\n\nObservational Study 2 (OS2) includes children, adolescents, and young adults with ASD, ADHD, or Developmental Coordination Disorder (DCD) to identify environmental and biological factors causally linked to anxiety and depression symptoms, and to support the development of personalised criteria for evidence-based interventions.\n\nApproximately 800 participants will be recruited across 10 international clinical sites. The study aims to generate multi-domain data to support predictive modelling and inform future personalised mental-health prevention strategies across childhood and young adulthood.",[89,90,27],"ADHD - Attention Deficit Disorder With Hyperactivity","Autism Spectrum Disorder (ASD)",[92,93,94],"Attention Deficit Disorder with Hyperactivity","Autism spectrum disorder","Developmental Coordination Disorder","2026-04-29",{"date":97,"type":34},"2026-05-06",{"date":38,"type":21},{"date":100,"type":21},"2028-12-31",{"name":102,"class":41},"University of Exeter",{"id":104,"slug":105,"hasResults":11,"nctId":106,"briefTitle":107,"officialTitle":108,"acronym":4,"eligibilityCriteria":109,"healthyVolunteers":11,"sex":16,"minAge":110,"maxAge":111,"enrollmentInfo":112,"targetDuration":4,"studyType":22,"phases":114,"briefSummary":115,"conditions":116,"keywords":118,"overallStatus":124,"whyStopped":4,"lastUpdateSubmitDate":125,"lastUpdatePostDateStruct":126,"startDateStruct":128,"completionDateStruct":130,"leadSponsor":132,"locationsCount":134},"100600049","pediatric-upper-limb-rehabilitation-with-phicube-a-modular-bilateral-end-effector-device-100600049","NCT07092436","Pediatric Upper-Limb Rehabilitation With PhiCube, a Modular Bilateral End-Effector Device","Pediatric Upper-Limb Rehabilitation With PhiCube, a Modular Bilateral End-Effector Device.","Inclusion Criteria:\n\n* For subjects with congenital and acquired neuromotor disorders:\n\n  * Diagnosis of congenital and acquired neuromotor disorders\n  * Age between 4 and 18 years at the time of recruitment\n  * Modified Ashworth Scale (MAS) less than 3\n  * MACS level I-IV\n  * Sufficient capacity to understand the proposed activities\n  * Availability to attend the facility\n* For subjects with developmental coordination disorder (DCD):\n\n  * Diagnosis of developmental coordination disorder (DCD)\n  * Age between 4 and 18 years at the time of recruitment\n  * Sufficient capacity to understand the proposed activities\n  * Availability to attend the facility\n\nExclusion Criteria:\n\n* For subjects with congenital and acquired neuromotor disorders:\n\n  * Severe sensory deficits\n  * Onset of pathologies that prevent participation\n  * Worsening of pre-existing comorbidities\n* For subjects with developmental coordination disorder (DCD):\n\n  * Severe sensory deficits\n  * Onset of pathologies that prevent participation\n  * Worsening of pre-existing comorbidities","4 Years","18 Years",{"count":113,"type":21},54,[24],"The present investigation is configured as a multicenter clinical study in a within-group pilot phase.\n\nThis study aims to investigate primarily the feasibility of use and effectiveness of a treatment for upper limb function in children aged 4 to 18 years with congenital and acquired neuromotor disorders through a new portable robotic system, called PhiCube, designed for bilateral neuromotor rehabilitation of the upper limbs in subjects with neuromotor disorders.\n\nIn order to specifically investigate also the potential impact of PhiCube on movement planning aspects, the study will also involve a small group of children aged 4 to 18 years with Developmental Coordination Disorder (DCD).\n\nBefore (PreT0 and T0) and after (T1 and T2) treatment, standardized assessment tests will be administered. Regarding the investigation objectives reported above, the primary outcome measure will be the Melbourne Assessment-2 (MA2), a standardized, valid and reliable instrument for evaluating the quality of upper limb movement in children with neurological deficits, capable of measuring four elements of movement quality: range of motion, accuracy, dexterity and fluency. As secondary outcome measures, Abilhand-Kids has been chosen, a brief questionnaire that measures 21 main daily bimanual activities completed by the parent or caregiver, and various subtests and questionnaires aimed at evaluating the neuropsychological processes involved and the effects related to auditory feedback perception.\n\nThe treatment will have a total duration of approximately 3 months and will be organized in 3 weekly sessions lasting 45 minutes each, to reach a total of 30.\n\nDescriptive statistics of the clinical and technological variables obtained in the evaluation and rehabilitation phases will be calculated. Subsequently, treatment efficacy analyses through the robotic device are planned, comparing pre-post clinical variables. All collected data will finally be analyzed in order to compare the rehabilitative efficacy of the device with respect to the different groups of participants identified based on diagnostic profile.",[117,27],"Congenital and Acquired Neuromotor Disorders",[119,120,121,122,123],"Pediatric Rehabilitation","Upper Limb Rehabilitation","Robotic Rehabilitation","Bilateral Training","Neuromotor Disorders","RECRUITING","2026-04-01",{"date":127,"type":34},"2026-04-02",{"date":129,"type":34},"2025-11-17",{"date":131,"type":21},"2026-11",{"name":133,"class":41},"Istituto di Sistemi e Tecnologie Industriali Intelligenti per il Manifatturiero Avanzato",6]